Abstract
Tumor invasion is paradigmatic of the complex interactions connecting a carcinoma with its environment, and a reflex of the cellular and molecular heterogeneity that defines the initiation of dissemination and metastasis. The hostile situation generated by a growing carcinoma and a reactive stroma is at the basis of the promotion of carcinoma invasion and metastasis, with oxidative stress emerging as a main player in the acquisition of an aggressive tumor phenotype. In this review, we present this complex scenario with a focus on the contribution of the reactive environment and the oxidative stress to the cellular and molecular events associated with carcinoma invasion and metastasis. We also discuss the potential of oxidative stress as a source of biomarkers of advance disease, and as supplier of a therapeutic armamentarium against the initial steps of metastatic dissemination.
Keywords: Anti-cancer therapy, biomarker, carcinoma invasion, hypoxia, inflammation, metastasis, oxidative stress, ROS, tumor dissemination, oncology, malignancy, tumor phenotype, microenvironment, genetic mutations, tissue homeostasis
Current Molecular Medicine
Title:Tumor Invasion and Oxidative Stress: Biomarkers and Therapeutic Strategies
Volume: 12 Issue: 6
Author(s): L. Muinelo-Romay, L. Alonso-Alconada, M. Alonso-Nocelo, J. Barbazan and M. Abal
Affiliation:
Keywords: Anti-cancer therapy, biomarker, carcinoma invasion, hypoxia, inflammation, metastasis, oxidative stress, ROS, tumor dissemination, oncology, malignancy, tumor phenotype, microenvironment, genetic mutations, tissue homeostasis
Abstract: Tumor invasion is paradigmatic of the complex interactions connecting a carcinoma with its environment, and a reflex of the cellular and molecular heterogeneity that defines the initiation of dissemination and metastasis. The hostile situation generated by a growing carcinoma and a reactive stroma is at the basis of the promotion of carcinoma invasion and metastasis, with oxidative stress emerging as a main player in the acquisition of an aggressive tumor phenotype. In this review, we present this complex scenario with a focus on the contribution of the reactive environment and the oxidative stress to the cellular and molecular events associated with carcinoma invasion and metastasis. We also discuss the potential of oxidative stress as a source of biomarkers of advance disease, and as supplier of a therapeutic armamentarium against the initial steps of metastatic dissemination.
Export Options
About this article
Cite this article as:
Muinelo-Romay L., Alonso-Alconada L., Alonso-Nocelo M., Barbazan J. and Abal M., Tumor Invasion and Oxidative Stress: Biomarkers and Therapeutic Strategies, Current Molecular Medicine 2012; 12 (6) . https://dx.doi.org/10.2174/156652412800792570
DOI https://dx.doi.org/10.2174/156652412800792570 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeted Taxane Delivery Systems: Recent Advances
Drug Delivery Letters Targeted Enzyme Prodrug Therapies
Mini-Reviews in Medicinal Chemistry Recent Advances and Challenges in Steroid Metabolomics for Biomarker Discovery
Current Medicinal Chemistry The Thyroid Gland: A Crossroad in Inflammation-Induced Carcinoma? An Ongoing Debate with New Therapeutic Potential.
Current Medicinal Chemistry The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets VEGF/VEGFR2 Autocrine Signaling Stimulates Metastasis in Prostate Cancer Cells
Current Angiogenesis (Discontinued) Preparation and Quality Control of <sup>111</sup>In-Plerixafor for Chemokine Receptor CXCR4
Recent Patents and Topics on Imaging (Discontinued) Vitamin D Intervention Trials in Critical Illness
Inflammation & Allergy - Drug Targets (Discontinued) Endometriosis and Perinatal Outcome - A Systematic Review of the Literature
Current Women`s Health Reviews Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family
Mini-Reviews in Medicinal Chemistry Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting
Current Cancer Drug Targets microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design DNA Vaccines for Prostate Cancer
Current Cancer Therapy Reviews Novel Insights Into c-Src
Current Pharmaceutical Design Clinical Applications of Mesenchymal Stem Cells in Laryngotracheal Reconstruction
Current Stem Cell Research & Therapy Temporal Expression of miRNAs in Laser Capture Microdissected Palate Medial Edge Epithelium from Tgfβ3<sup>-/-</sup> Mouse Fetuses
MicroRNA Recent Approaches in Chemoprevention of Prostate Cancer
Current Cancer Drug Targets Cancer Microbiome; Opportunities and Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Integrin α4β7 Antagonists: Activities, Mechanisms of Action and Therapeutic Prospects
Current Immunology Reviews (Discontinued) Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer
Current Drug Targets